The use of phenylbutazone in the horse.

The research article focuses on the rules and effects of using phenylbutazone, a nonsteroidal anti-inflammatory drug (NSAID), in race horses in the United States. The authors examine different models to determine the impact, duration, and residual effects of phenylbutazone, while raising concerns over its potential effects on horse health and competition injuries.

Historical Perspective of Regulated Medication

• This section of the paper covers the history and development of regulations concerning medication in the US racing industry. The focus is on the nonsteroidal anti-inflammatory drug (NSAID) phenylbutazone (PBZ), popularly used in the industry.
• The researchers present a timeline or “historical guideposts” that led to the current rules governing the use of PBZ in US racing jurisdictions.

Phenylbutazone in Focus

• Due to its extensive use, attention is particularly focused on PBZ. The study aims to understand its impact and duration in horses.
• The research delved into different models that are used to evaluate these effects. These include models focusing on naturally occurring lameness and reversible-induced lameness, which review the effects and duration of PBZ administration at varying dosages.
• Moreover, the researchers also explored indirect plasma and tissue models that study the suppression of arachidonic acid-derived mediators of inflammation.

Impact of Phenylbutazone

• The majority of studies suggest that PBZ has effects on horses at 24 hours when administered at 4.4 mg/kg. This finding aligns with the opinion of many clinical veterinarians who will not perform a pre-purchase lameness examination unless a horse is free of NSAIDs.
• This view persists among many regulatory veterinarians, responsible for pre-race examinations, as they prefer to evaluate a horse without any possibility of interference from NSAIDs that could mask potential musculoskeletal conditions.
• The study raises the issue that even after 24 hours, scientific evidence suggests residual effects of PBZ. The document flags concerns over the prolonged effect impacting the health and welfare of the horse and potentially contributing to injuries during competition.